摘要
目的:探讨甘肃省武威地区胃癌患者EB病毒(Epstein-Barr virus,EBV)感染状况及miR-101、EZH2、COX-2在EBV相关胃癌发生发展中的作用。方法:应用组织芯片、原位杂交和免疫组织化学技术检测120例胃癌组织及相应癌旁组织中EBV小RNA(EBER)、miR-101、EZH2、COX-2的表达情况。结果:120例胃癌组织EBV阳性率为10.0%,EBV相关胃癌有较少的淋巴结转移,好发于贲门、胃体(P<0.05)。miR-101、EZH2、COX-2在120例胃癌组织和相应癌旁组织的阳性率差异有统计学意义(P<0.05)。12例EBV阳性胃癌组织miR-101、EZH2、COX-2和108例EBV阴性胃癌组织3个分子的表达率差异有统计学意义(P<0.05)。胃癌组织EBV感染和miR-101表达呈正相关,EBV相关胃癌组织miR-101表达和淋巴结转移、COX-2、EZH2表达均呈负相关(P<0.05)。结论:EB病毒感染与武威地区胃癌的发生有一定关系;EBV相关胃癌和EBV阴性胃癌在淋巴结转移和发生部位的差异有统计学意义;miR-101、EZH2、COX-2与EB病毒相关胃癌的发展有一定关系。
Objective:This study was conducted to investigate Epstein-Barr virus (EBV) infection in gastric cancer in Wuwei ar-ea of Gansu province (China) and the roles of miR-101, EZH2, and COX-2 in EBV-associated gastric carcinomas (EBVaGC). Meth-ods:Tissue microarray technique, immunohistochemistry, and in situ hybridization were performed to detect the expression of EBV-en-coded small RNAs (EBERs), miR-101, EZH2, and COX-2, in gastric cancer tissues (n=120) and the corresponding adjacent tissues (n=120). Results:The positive rate of EBV was 10.0% in 120 cases of gastric cancer tissues. EBVaGC was not significantly associated with lymph node metastasis and developed most often in the cardia and body (P&lt;0.05). The differences in the positive rates of miR-101, EZH2, and COX-2 in 120 cases of gastric cancer tissues and corresponding adjacent tissues were significant (P&lt;0.05). The differences in the positive rates of miR-101, EZH2, and COX-2 in 12 cases of EBVaGC and in 108 cases of EBV-negative gastric can-cer (EBVnGC) tissues were significant (P&lt;0.05). The infection of EBV in gastric cancer tissues was positively related to miR-101 ex-pression. By contrast, miR-101 expression was negatively related to lymph node metastasis and expression of COX-2 and EZH2 in EB-VaGC tissues (P&lt;0.05). Conclusion:EBV infection was related to gastric cancer in Wuwei area of Gansu province. EBVaGC and EB-VnGC have significant differences in lymph node metastasis and in the location of cancer. MiR-101, EZH2, and COX-2 were related to the development of EBVaGC.
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
2014年第7期420-424,共5页
Chinese Journal of Clinical Oncology
基金
国家自然科学基金项目(编号:81372145)
甘肃省卫生行业科研计划项目(编号:GSWST09-03)资助~~